{"nctId":"NCT03260569","briefTitle":"Inhaled Nitric Oxide in Brain Injury","startDateStruct":{"date":"2018-12-12","type":"ACTUAL"},"conditions":["Traumatic Brain Injury"],"count":13,"armGroups":[{"label":"Inhaled Nitric Oxide","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Inhaled Nitric Oxide"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Inhaled Nitric Oxide","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Hospital admission with traumatic brain injury (penetrating or blunt)\n* Requirement for mechanical ventilation\n* Glasgow Coma Score \\> 3\n\nExclusion Criteria:\n\n* Brain death\n* Expected survival \\< 48 hours\n* Air leak (bronchopleural fistula, tracheal injury)\n* Current inspired oxygen concentration (FiO2) \\> 0.65\n* Hemodynamic instability (systolic blood pressure \\< 100 mm Hg, cardiac arrhythmia)\n* Uncontrolled intracranial pressure (\\> 20 mm Hg)\n* Spinal cord injury with hypotension\n* Severe acute respiratory distress syndrome (ARDS) (PaO2/FiO2 \\< 100)\n* Chest abbreviated injury score (AIS) \\> 3\n* First rib fracture\n* Flail chest","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"PaO2","description":"The primary endpoint is the difference in PO2","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"115","spread":"10"},{"groupId":"OG001","value":"95","spread":"10"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":6},"commonTop":[]}}}